- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 56.2M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 57.54M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 40.71M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$21.34M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$14.71M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $14.74M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $49.66M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $181.21M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $196.41M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $158.48M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $167.13M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.92M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.94M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.72M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $13.06M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $140M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $159.5M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $191.92M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $209.47M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.31 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.29 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.31 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.29 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.07M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $4.98M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $13.56M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $9.15M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$17.78M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$11.91M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$19.63M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$14.12M |
| Capex | Q1 2026 · Mar 31, 2025 | $44K |